These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16840744)

  • 1. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
    Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
    Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
    Sweiss NJ; Barnathan ES; Lo K; Judson MA; Baughman R;
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):49-56. PubMed ID: 21086905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
    Rennard SI; Fogarty C; Kelsen S; Long W; Ramsdell J; Allison J; Mahler D; Saadeh C; Siler T; Snell P; Korenblat P; Smith W; Kaye M; Mandel M; Andrews C; Prabhu R; Donohue JF; Watt R; Lo KH; Schlenker-Herceg R; Barnathan ES; Murray J;
    Am J Respir Crit Care Med; 2007 May; 175(9):926-34. PubMed ID: 17290043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
    Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
    Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of infliximab on refractory sarcoidosis.
    Ørum M; Hilberg O; Krag S; Bendstrup E
    Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
    Gottlieb AB; Evans R; Li S; Dooley LT; Guzzo CA; Baker D; Bala M; Marano CW; Menter A
    J Am Acad Dermatol; 2004 Oct; 51(4):534-42. PubMed ID: 15389187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
    Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First study of infliximab treatment in patients with chronic obstructive pulmonary disease.
    van der Vaart H; Koëter GH; Postma DS; Kauffman HF; ten Hacken NH
    Am J Respir Crit Care Med; 2005 Aug; 172(4):465-9. PubMed ID: 15937294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.
    Hommes DW; Erkelens W; Ponsioen C; Stokkers P; Rauws E; van der Spek M; ten Kate F; van Deventer SJ
    J Clin Gastroenterol; 2008; 42(5):522-6. PubMed ID: 18344886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
    Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
    Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for treating sarcoidosis patients, Portuguese experience.
    Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
    Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infliximab treatment for chronic sarcoidosis--a case series].
    Jounieaux F; Chapelon C; Valeyre D; Israel Biet D; Cottin V; Tazi A; Fournier E; Wallaert B;
    Rev Mal Respir; 2010 Sep; 27(7):685-92. PubMed ID: 20863968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The St. George's Respiratory Questionnaire in Pulmonary Sarcoidosis.
    Lo KH; Donohue J; Judson MA; Wu Y; Barnathan ES; Baughman RP;
    Lung; 2020 Dec; 198(6):917-924. PubMed ID: 32979072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
    Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.
    Reich K; Nestle FO; Wu Y; Bala M; Eisenberg D; Guzzo C; Li S; Dooley LT; Griffiths CE
    Eur J Dermatol; 2007; 17(5):381-6. PubMed ID: 17673380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.
    Erin EM; Leaker BR; Nicholson GC; Tan AJ; Green LM; Neighbour H; Zacharasiewicz AS; Turner J; Barnathan ES; Kon OM; Barnes PJ; Hansel TT
    Am J Respir Crit Care Med; 2006 Oct; 174(7):753-62. PubMed ID: 16840747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.